Login
Navigate Fool.com
Will VRTX beat
the market?

Vertex Pharmaceuticals

NASDAQ: VRTX

Community Rating: 3 Stars: Appealing

63.25 0.81 (1.30%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $62.83
Previous Close $62.44
Daily Range $59.79 - $63.97
52-Week Range $51.96 - $89.96
Market Cap $14.9B
P/E Ratio -31.85
Dividend (Yield) $0.00 (0.0%)
Volume 1,886,008
Average Daily Volume 1,606,193
Current FY EPS -$2.26

How do you think VRTX
will perform against the market?

Top VRTX Bull/Bear Pitches

 

mfgd (< 20)
Submitted April 28, 2011

Vertex (VRTX) shares have been halted as an FDA advisory panel will review its telaprevir NDA today 7:05 am ET 04/28/2011- Sounds like GOOD NEWS!

1 Replies Reply Report this Post
 

zzlangerhans (< 20)
Submitted April 15, 2008

I won't spend much time knocking telaprevir or the rest of the pipeline, as it seems there's a lot of potential there. But a market cap of 3.6 billion? In this environment for biotech? With a quarterl … More

0 Replies Reply Report this Post

News & Commentary Rss Feed

Why Biogen Idec Inc., Vertex Pharmaceuticals Incorporated, and Broadcom Corp. Are Today’s 3 Worst St

Health-care and high-growth names continue to stumble as a sell-off continues in the stock market today.

Tech stock rout continues in Asia

Asia tech stocks fall into the red

Stocks: Wall Street wears red

S&P 500 Analyst Moves: VRTX

Why Biogen Idec, Vertex Pharmaceuticals, and PG&E Are Today’s 3 Worst Stocks

From federal lawsuits to federal scrutiny, these three stocks ended as the worst in the stock market today

Are These 2 Biotech Value Plays Value Traps?

Two biotechs currently trading at deep discounts relative to forward earnings.

First Solar, H-P, Symantec are stocks to watch

3 Biotechs Expecting Data

Exelixis, Vertex Pharmaceuticals, and Prana Biotechnology expect to release data this year.

BioMed Realty Trust Leases Space To Life Science Firms

Vertex Pharmacueticals Inc Approaching a Huge Fork in the Road

Wall Street seems almost evenly split on the odds that Vertex will find success in combo therapies for cystic fibrosis.

See More VRTX News...

Sector

Healthcare

Industry

Drugs

Vertex Pharmaceuticals (VRTX) Description

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Website: http://www.vrtx.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks